Literature DB >> 2010754

Scales for rating motor impairment in Parkinson's disease: studies of reliability and convergent validity.

L Henderson1, C Kennard, T J Crawford, S Day, B S Everitt, S Goodrich, F Jones, D M Park.   

Abstract

Study 1 examined the reliability of the ratings assigned to the performance of five sign-and-symptom items drawn from tests of motor impairment in Parkinson's disease. Patients with Parkinson's disease of varying severity performed gait, rising from chair, and hand function items. Video recordings of these performances were rated by a large sample of experienced and inexperienced neurologists and by psychology undergraduates, using a four point scale. Inter-rater reliability was moderately high, being higher for gait than hand function items. Clinical experience proved to have no systematic effect on ratings or their reliability. The idiosyncrasy of particular performances was a major source of unreliable ratings. Study 2 examined the intercorrelation of several standard rating scales, comprised of sign-and-symptom items as well as activities of daily living. The correlation between scales was high, ranging from 0.70 to 0.83, despite considerable differences in item composition. Inter-item correlations showed that the internal cohesion of the tests was high, especially for the self-care scale. Regression analysis showed that the relationship between the scales could be efficiently captured by a small selection of test items, allowing the construction of a much briefer test.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2010754      PMCID: PMC1014292          DOI: 10.1136/jnnp.54.1.18

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  9 in total

1.  A method for evaluating disability in patients with Parkinson's disease.

Authors:  G J CANTER; R DE LA TORRE; M MIER
Journal:  J Nerv Ment Dis       Date:  1961-08       Impact factor: 2.254

2.  Critical analysis of the disability in Parkinson's disease.

Authors:  D D Webster
Journal:  Mod Treat       Date:  1968-03

3.  Evaluation of Parkinson's disease: reliability of three rating scales.

Authors:  A Ginanneschi; F Degl'Innocenti; S Magnolfi; M T Maurello; L Catarzi; P Marini; L Amaducci
Journal:  Neuroepidemiology       Date:  1988       Impact factor: 3.282

4.  The reliability of clinical assessment of Parkinson's disease.

Authors:  C Kennard; A J Munro; D M Park
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-03       Impact factor: 10.154

5.  Evaluating the evaluations: or how to weigh the scales of parkinsonian disability.

Authors:  S G Diamond; C H Markham
Journal:  Neurology       Date:  1983-08       Impact factor: 9.910

Review 6.  Assessment of extrapyramidal disorders.

Authors:  C D Marsden; M Schachter
Journal:  Br J Clin Pharmacol       Date:  1981-02       Impact factor: 4.335

7.  Scientific and clinical problems in indexes of functional disability.

Authors:  A R Feinstein; B R Josephy; C K Wells
Journal:  Ann Intern Med       Date:  1986-09       Impact factor: 25.391

8.  Factor analysis of Parkinson's impairment. An evaluation of the final common pathway.

Authors:  N C Reynolds; G K Montgomery
Journal:  Arch Neurol       Date:  1987-10

9.  Accuracy of self-reported disability in patients with parkinsonism.

Authors:  R G Brown; B MacCarthy; M Jahanshahi; C D Marsden
Journal:  Arch Neurol       Date:  1989-09
  9 in total
  13 in total

1.  Gait quantitation in Parkinson's disease--locomotor disability and correlation to clinical rating scales.

Authors:  P Vieregge; H Stolze; C Klein; I Heberlein
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

2.  Psychometric Properties of Activity, Self-Efficacy, and Quality-of-Life Measures in Individuals with Parkinson Disease.

Authors:  Vanina Dal Bello-Haas; Laura Klassen; M Suzanne Sheppard; Amy Metcalfe
Journal:  Physiother Can       Date:  2011-01-20       Impact factor: 1.037

3.  Influence of clinical and demographic variables on quality of life in patients with Parkinson's disease.

Authors:  K H Karlsen; J P Larsen; E Tandberg; J G Maeland
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-04       Impact factor: 10.154

4.  Parkinson's disease.

Authors:  D Mukherjee; I R Hastie
Journal:  Postgrad Med J       Date:  1995-04       Impact factor: 2.401

5.  The modified bradykinesia rating scale for Parkinson's disease: reliability and comparison with kinematic measures.

Authors:  Dustin A Heldman; Joseph P Giuffrida; Robert Chen; Megan Payne; Filomena Mazzella; Andrew P Duker; Alok Sahay; Sang Jin Kim; Fredy J Revilla; Alberto J Espay
Journal:  Mov Disord       Date:  2011-04-29       Impact factor: 10.338

6.  Bradykinesia akinesia inco-ordination test (BRAIN TEST): an objective computerised assessment of upper limb motor function.

Authors:  G Giovannoni; J van Schalkwyk; V U Fritz; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-11       Impact factor: 10.154

7.  A systematic review of local field potential physiomarkers in Parkinson's disease: from clinical correlations to adaptive deep brain stimulation algorithms.

Authors:  Bernadette C M van Wijk; Rob M A de Bie; Martijn Beudel
Journal:  J Neurol       Date:  2022-10-08       Impact factor: 6.682

8.  Abbreviated MDS-UPDRS for Remote Monitoring in PD Identified Using Exhaustive Computational Search.

Authors:  Gareth Morinan; Robert A Hauser; Anette Schrag; Jingxuan Tang; Jonathan O'Keeffe
Journal:  Parkinsons Dis       Date:  2022-06-07

9.  The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease.

Authors:  V Peto; C Jenkinson; R Fitzpatrick; R Greenhall
Journal:  Qual Life Res       Date:  1995-06       Impact factor: 4.147

10.  Quantitative assessment of finger tapping characteristics in mild cognitive impairment, Alzheimer's disease, and Parkinson's disease.

Authors:  David R Roalf; Petra Rupert; Dawn Mechanic-Hamilton; Laura Brennan; John E Duda; Daniel Weintraub; John Q Trojanowski; David Wolk; Paul J Moberg
Journal:  J Neurol       Date:  2018-04-04       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.